Development of an in vitro assay and demonstration of Plasmodium berghei liver-stage inhibition by TRAP-specific CD8+ T cells
The development of an efficacious vaccine against the Plasmodium parasite remains a top priority. Previous research has demonstrated the ability of a prime-boost virally vectored sub-unit vaccination regimen, delivering the liver-stage expressed malaria antigen TRAP, to produce high levels of antige...
Main Authors: | Longley, R, Bauza, K, Ewer, K, Hill, A, Spencer, A |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Public Library of Science
2015
|
Registos relacionados
-
Development of an in vitro assay and demonstration of Plasmodium berghei liver-stage inhibition by TRAP-specific CD8+ T cells.
Por: Rhea J Longley, et al.
Publicado em: (2015-01-01) -
An in vitro T cell killing assay to assess new Plasmodium falciparum vaccine candidates
Por: Longley, R, et al.
Publicado em: (2013) -
Malaria vaccines: identifying Plasmodium falciparum liver-stage targets
Por: Longley, R, et al.
Publicado em: (2015) -
The importance of the immunodominant CD8+ T cell epitope of Plasmodium berghei circumsporozoite protein in parasite- and vaccine-induced protection
Por: Gibbins, MP, et al.
Publicado em: (2020) -
Immunization with radiation-attenuated Plasmodium berghei sporozoites induces liver cCD8alpha+DC that activate CD8+T cells against liver-stage malaria.
Por: Ousman Jobe, et al.
Publicado em: (2009-01-01)